Yüklüyor......
The in vivo Anti‐tumor Effect of Human Recombinant Interleukin‐6
Administration of recombinant interleukin‐6 (IL‐6) was found to induce in vivo generation of cytotoxic T lymphocytes (CTL) against syngeneic transplantable erythroleukemia (FBL‐3) in lymph node cells and peritoneal exudate cells (PEC) in C57BL/6 mice. Furthermore, 15 out of 16 C57BL/6 mice injected...
Kaydedildi:
| Yayımlandı: | Jpn J Cancer Res |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Blackwell Publishing Ltd
1990
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5917969/ https://ncbi.nlm.nih.gov/pubmed/2121676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1990.tb03342.x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|